The stock of 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) last traded at $0.18, down -13.02% from the previous session.
SXTP stock price is now -30.50% away from the 50-day moving average and -60.29% away from the 200-day moving average. The market capitalization of the company currently stands at $2.25M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
In other news, XU CHERYL, Director bought 200,000 shares of the company’s stock on Jan 31 ’24. The stock was bought for $75,000 at an average price of $0.38. Upon completion of the transaction, the Director now directly owns 424,934 shares in the company, valued at $76488.12. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 31 ’24, President and CEO DOW GEOFFREY S bought 25,974 shares of the business’s stock. A total of $9,740 was incurred on buying the stock at an average price of $0.38. This leaves the insider owning 703,599 shares of the company worth $0.13 million. A total of 23.67% of the company’s stock is owned by insiders.
During the past 12 months, 60 Degrees Pharmaceuticals Inc has had a low of $0.20 and a high of $2.65. As of last week, the company has a debt-to-equity ratio of 0.02, a current ratio of 7.16, and a quick ratio of 6.77. The fifty day moving average price for SXTP is $0.26448 and a two-hundred day moving average price translates $0.46178 for the stock.
The latest earnings results from 60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) was released for 2024-03-31. The company reported revenue of $0.15 million for the quarter, compared to $22000.0 a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 563.64 percent.
